Holo-transcobalamin concentration and transcobalamin saturation reflect recent vitamin B12 absorption better than does serum vitamin B12

被引:57
作者
Bor, MV [1 ]
Nexo, E [1 ]
Hvas, AM [1 ]
机构
[1] Aarhus Univ Hosp, AKH, Dept Clin Biochem, DK-8000 Aarhus C, Denmark
关键词
D O I
10.1373/clinchem.2003.027458
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: We evaluated whether measurement of vitamin B-12-saturated transcobalamin (holo-TC) concentrations or TC saturation (holo-TC:total TO reflects active vitamin B-12 absorption in healthy individuals and patients after vitamin B-12 intake. Methods: We obtained blood samples from 31 healthy individuals (age range, 25-57 years) before (days -1 and 0) and after (days 1, 2, and 6) oral administration of three 9-mug doses of vitamin B12. The blood samples from seven patients (age range, 22-39 years) suspected to have decreased vitamin B-12 absorption were obtained before and 1 day after the vitamin B-12 intake. The blood samples were analyzed for vitamin B-12, total TC, and holo-TC. The TC saturation was calculated. Results: Intraindividual variation was <13% for all measured values, as calculated from samples removed on day -1 and 0. In healthy individuals (n = 31) after intake of vitamin B-12, the maximum median (range) increase (as percentages and absolute values) was in TC saturation [52 (-2% to 128)% and 0.04 (0-0.23) as a fraction], closely followed by holo-TC concentrations [39 (0-108)% and 34 (0-149) pmol/L]. All but one healthy individual had an increase of greater than or equal to15% in these markers. Serum vitamin B-12 showed a smaller increase [14 (-8 to 51)% and 36 (-27 to 290) pmol/L]. After vitamin B-12 intake, three patients with Crohn disease had the lowest increases in holo-TC concentration (3, 7, and 14 pmol/L) and in TC saturation (0.004, 0.01, and 0.01) among patients and 30 healthy individuals. Conclusion: Holo-TC concentrations and TC saturation reflect normal vitamin B-12 absorption better than does serum vitamin B-12. (C) 2004 American Association for Clinical Chemistry.
引用
收藏
页码:1043 / 1049
页数:7
相关论文
共 23 条
[1]  
CHANARIN I, 1979, MEGALOBLASTIC ANAEMI, P93
[2]   CHANGES IN CIRCULATING TRANSCOBALAMIN-II AFTER INJECTION OF CYANOCOBALAMIN [J].
DONALDSON, RM ;
BRAND, M ;
SERFILIPPI, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (25) :1427-1430
[3]  
HEINRICH HC, 1990, BIOMEDICINE PHYSL VI, P51
[4]   THE SCHILLING TEST CANNOT BE REPLACED BY AN ABSORPTION TEST WITH UNLABELED VITAMIN-B12 [J].
HENZE, E ;
MANNER, S ;
CLAUSEN, M ;
MALFERTHEINER, P ;
HELLWIG, D ;
DITSCHUNEIT, H ;
KORNHUBER, H ;
ADAM, WE .
KLINISCHE WOCHENSCHRIFT, 1988, 66 (08) :332-336
[5]   LOW HOLOTRANSCOBALAMIN-II IS THE EARLIEST SERUM MARKER FOR SUBNORMAL VITAMIN-B12 (COBALAMIN) ABSORPTION IN PATIENTS WITH AIDS [J].
HERBERT, V ;
FONG, W ;
GULLE, V ;
STOPLER, T .
AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (02) :132-139
[6]  
HERZLICH B, 1988, LAB INVEST, V58, P332
[7]   Practitioners' guide to meeting the vitamin B-12 - Recommended Dietary Allowance for people aged 51 years and older [J].
Ho, C ;
Kauwell, GPA ;
Bailey, LB .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1999, 99 (06) :725-727
[8]  
HOM BL, 1967, SCAND J HAEMATOL, V4, P321
[9]   PLASMA CLEARANCE OF 57COBALT-LABELLED VITAMIN B12 BOUND IN VITRO AND IN VIVO TO TRANSCOBALAMIN .I. AND .2 [J].
HOM, BL ;
OLESEN, HA .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1969, 23 (03) :201-&
[10]  
MAGNUS E, 1995, EUR J HAEMATOL, V54, P117